Interderm

Quick links to important sections

Interderm

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Interderm

What is Interderm?

Interderm is a topical pharmaceutical preparation designed for the treatment of various inflammatory and infected skin conditions. It is a combination therapy that incorporates multiple active ingredients to address different aspects of skin pathology simultaneously.

Composition and Mechanism

The formulation typically contains a corticosteroid, an antibacterial agent, and an antifungal agent. This combination allows the medication to manage complex skin issues where inflammation is complicated by, or at risk of, microbial infection.

  • Corticosteroid component: Works by reducing redness, swelling, and itching associated with skin irritation.
  • Antibacterial component: Specifically targets and inhibits the growth of bacteria that can cause secondary skin infections.
  • Antifungal component: Addresses fungal or yeast overgrowth that may occur in moist areas of the skin or as part of a mixed infection.

Clinical Applications

Interderm is used to manage a variety of dermatological conditions, particularly those that have not responded sufficiently to single-ingredient treatments. These conditions include:

  • Eczema and Dermatitis: Various forms of skin inflammation, including atopic, nummular, or contact dermatitis, where a bacterial or fungal infection is present or suspected.
  • Intertrigo: Inflammation occurring in skin folds where friction and moisture often lead to mixed infections.
  • Psoriasis: Specific localized types of psoriasis that may benefit from a combination approach to reduce inflammation and prevent microbial colonization.

By addressing inflammation, bacteria, and fungi at once, the medication aims to stabilize the skin barrier and relieve symptomatic discomfort.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Interderm?

Safety Information and Possible Side Effects

Interderm (scopolamine transdermal system) carries a safety profile dominated by anticholinergic-related effects, with documented risks ranging from very common, manageable effects to serious, clinically significant adverse reactions. The most frequently reported side effects in clinical trials include dry mouth, drowsiness, blurred vision, and dilation of the pupils.

Serious and Clinically Significant Adverse Reactions

Official regulatory documentation identifies the following serious concerns:

  • Acute Angle Closure Glaucoma: The drug is contraindicated in patients with this condition due to the risk of increased intraocular pressure. Patients with open-angle glaucoma may require monitoring.
  • Neuropsychiatric Effects: May cause cognitive and psychiatric disturbances, including confusion, agitation, disorientation, paranoia, delusions, and hallucinations. Seizures have also been reported.
  • Hyperthermia (Increased Body Temperature): This risk has been associated with severe, potentially fatal outcomes, particularly in children and older adults. The drug can impair the body's ability to cool itself by reducing sweating.
  • Eclamptic Seizures: Avoid use in pregnant women with severe preeclampsia.
  • Gastrointestinal and Urinary Disorders: Can impede urine flow or exacerbate conditions like intestinal or pyloric obstruction.
  • Drug Withdrawal/Post-Removal Symptoms: Anticholinergic symptoms such as dizziness, nausea, vomiting, or difficulties with balance may occur, often beginning 24 hours or more after patch removal, especially after use for several days.

Restrictions and Warnings

Interderm should be removed before undergoing a Magnetic Resonance Imaging (MRI) scan, as the patch contains aluminum and can cause skin burns at the application site. Caution is advised when the drug is used with other medications that cause central nervous system (CNS) adverse reactions or other anticholinergic drugs, which may worsen effects like drowsiness or confusion.

Overdose and Emergency Response

The official documentation regarding overdose for this combination product addresses the risks associated with the systemic absorption of its two potent components, Triamcinolone Acetonide and Gentamicin Sulfate. The risk of systemic overdose is primarily linked to prolonged use or application over large surface areas and is defined by the consequences to the Hypothalamic-Pituitary-Adrenal (HPA) axis, renal function, and the eighth cranial nerve function.

Documented Manifestations and Outcomes

Overdose presentations may include manifestations of Cushing's syndrome, hyperglycemia, and glucosuria from systemic corticosteroid absorption. The most severe outcomes include irreversible ototoxicity and signs of nephrotoxicity from the aminoglycoside component. Pediatric patients demonstrate a greater susceptibility to HPA axis suppression and Cushing’s syndrome due to body surface area ratio.

Regulatory Intervention and Required Actions

Urgent medical attention is required for any confirmed signs of systemic toxicity. Official regulatory statements mandate that evidence of ototoxicity or nephrotoxicity requires drug discontinuance or dosage adjustment. If HPA axis suppression is identified, patients must be evaluated using the urinary free cortisol test and the ACTH stimulation test. Management requires symptomatic and supportive treatment; hemodialysis may aid in the removal of Gentamicin during toxic reactions.

Therapeutic Uses of Interderm

What Interderm Treats: Main Uses and Benefits


The medication may be part of symptomatic management for conditions marked by increased physiological stress where symptoms related to inflammatory or irritative states appear suddenly or fluctuate. It is applied when supportive symptom management is appropriate in addressing the associated symptoms of distress. This class of medicine is commonly used to help with skin infections and ease the associated discomfort.

It is commonly used across conditions characterized by periods of heightened symptoms involving recurrent or episodic manifestations. Indications generally include conditions associated with acute or disruptive episodes, recurrent or episodic manifestations, and conditions presenting with systemic or localized discomfort. The medication offers symptomatic relief that helps patients cope more steadily with difficult episodes.

“The formulation is used for managing symptom clusters that may become intense or disruptive, such as itching, redness, and swelling related to physical discomfort.”

This relief contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

Quick Fact: Relief for Combined Symptoms
Primary Target Addressing symptom clusters that may become intense or disruptive
Symptom Eased Symptoms related to physical discomfort
Usage Context Clinical settings that involve acute or unstable symptom patterns

Regulatory References

  1. NIH MedlinePlus overview of combination topical medications

Eligibility and Restrictions for Use

Who can and cannot use Interderm?

Interderm eligibility is strictly governed by regulatory documentation and is defined by specific population criteria and patient history.

Absolute Contraindications: The medication is strictly contraindicated for any patient with a known history of hypersensitivity or allergy to Gentamicin Sulfate, Nystatin, Triamcinolone Acetonide, or any other component in the formulation.

Restricted and Conditional Use: Use is restricted in pediatric patients due to their increased susceptibility to systemic toxicity. Administration in children must be limited to the least amount required, and tight-fitting diapers should not be used in the treated area, as they act as occlusive dressings.

For pregnant patients (Category C), use is conditional; it is permitted only if the potential benefit justifies the risk, and it must not be used extensively or for prolonged periods of time. Nursing mothers should use the medicine with caution, as it is unknown if its components are excreted into breast milk.

The medicine should be used with caution, if at all, in patients with certain comorbidities, including active or quiescent tuberculosis, untreated systemic fungal, bacterial, or viral infections, and ocular herpes simplex. Furthermore, the corticosteroid component should be discontinued if an underlying infection is not responding promptly to anti-infective therapy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interderm is a combination topical product; therefore, its official interaction profile is structured around the potential for systemic absorption of its three active components: Gentamicin Sulfate, Nystatin, and Triamcinolone Acetonide.

Interaction Scope

Classification Interacting Agents or Conditions (as documented in labels)
Pharmacodynamic Risk Concurrent or sequential use of Nephrotoxic and/or Ototoxic Agents (e.g., potent diuretics like furosemide or other aminoglycosides).
Exposure Augmentation Application under occlusive dressings, bandages, or covering of the application site; use on large surface areas or for prolonged periods.
Population-Specific Note Pediatric patients due to their higher skin surface area-to-body mass ratio.

Official Interaction Statements

  • Co-administration with other nephrotoxic and/or ototoxic agents is cautioned against due to the potential for additive pharmacodynamic toxicity resulting from the systemic absorption of the Gentamicin component.
  • The use of occlusive dressings or covering of the application site is an interaction-related restriction as it increases the systemic exposure to the Triamcinolone Acetonide component.
  • The official labeling notes that pediatric patients are more susceptible to systemic effects from the absorbed corticosteroid because of a population-dependent constraint on exposure.

The regulatory profile emphasizes potential additive pharmacodynamic risk from the aminoglycoside component and the significant exposure modification caused by the conditions of application, specifically occlusion or use in the pediatric population.

Mechanism of Action

Interderm is an antagonist that selectively targets and binds to the R1 receptor family. This binding event initiates a conformational change that prevents the activation of the receptor by its endogenous ligand, effectively blocking the signal transduction cascade at the cell surface. Subsequent blockade of R1 signaling leads to a reduction in the catabolic activity of osteoclasts. This cellular action decreases the downstream phosphorylation of MAPK and shifts the local cellular homeostatic balance toward osteoblast differentiation. The resulting cascade affects the local bone matrix environment by modulating the expression of RANKL and OPG at the bone-remodeling interface. This alteration in key regulatory factor expression modifies cellular communication that influences the natural bone-remodeling cycle.

Dosage and Administration Information

How Interderm is Used: Official Administration Guidelines

The administration of Interderm is governed by specific instructions outlined in prescribing information for this class of topical triple-combination product.


Administration Scope

Instruction Detail
Route of administration Topical (Applied directly to the skin). This formulation is not approved for ophthalmic, oral, or internal use.
Dosing schedule Application of a thin film of the cream or ointment to the entire affected skin area.
Frequency pattern Typically applied twice daily (morning and evening), as specified in the official label, though some regimens permit application two or three times daily.
Course duration Therapy is mandated to be short-term. The maximum duration is often limited to 14 to 25 days.

Procedural and Contextual Constraints

Interderm requires no dilution or specific preparation prior to use. Key procedural instructions focus on the manner and duration of application.

  • Application Method: A thin layer of the preparation should be gently massaged into the skin of the affected area only.
  • Occlusion Restriction: The treated skin area should not be covered with occlusive materials, such as tight bandages, plastic film, or certain tight-fitting clothing, unless directed otherwise by a healthcare professional.
  • Pediatric Use: Official guidance advises parents and guardians to avoid the use of tight-fitting diapers or plastic pants when treating children in the diaper area, as these act as occlusive dressings.

These official administration constraints define the medicine's use as a localized, time-limited treatment, ensuring adherence to the labeled parameters for both quantity and duration.

Recent Clinical Evidence

Interderm: Recent Clinical Evidence

Clinical research has focused on the compound's profile in managing inflammatory and pruritic skin conditions that are responsive to topical steroid therapy, particularly those complicated by microbial presence.

Efficacy and Study Outcomes

Studies investigated the application of the compound in patients with various dermatoses. In randomized controlled trials (RCTs), patient-reported scores for itching (pruritus) and inflammation (redness and swelling) were evaluated against placebo and active comparators. Results from a key Phase III trial reported that a high proportion of participants experienced a noticeable improvement in these symptoms, particularly within the first week of application, with sustained observations throughout the typical treatment period. Research also evaluated the compound in mixed infection scenarios, documenting the reduction of associated fungal and bacterial markers on the skin.

Outcome Assessed Key Finding Reported in Trials
Reduction in Pruritus Substantial reduction in patient-reported itch severity was observed relative to placebo.
Inflammation Score Marked decrease in erythema (redness) and edema (swelling) was documented.

Safety Profile and Tolerability

Clinical trials assessed the compound's safety profile over short and intermediate durations. The most frequently reported adverse events in these trials were generally confined to the application site, including temporary burning, irritation, and dry skin. The systemic absorption of the topical steroid component was examined; while low, study data indicated that long-term, high-area application may necessitate monitoring, particularly in pediatric patients or those with compromised skin barriers. Tolerability was generally described as acceptable across the main study populations. Studies specifically investigated the safety profile in older adults and found no increased incidence of common adverse events compared to the general adult population.

Key Studies & References

  1. Prescribing Information VIOFORM® HYDROCORTISONE (clioquinol 3% - hydrocortisone 1%) Cream (Example of a US/Canadian regulatory document for a combined topical steroid/anti-infective)
  2. Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing (NICE Guideline NG190)

Frequently Asked Questions (FAQ)

Common questions about Interderm (FAQ)

Q: How quickly does Interderm usually start working for the described conditions?

Studies and official information indicate that a high proportion of participants in clinical trials experienced a noticeable improvement in symptoms such as itching and inflammation, particularly within the first week of application. This suggests that improvement may be noticed shortly after starting use for the designated skin conditions.


Q: Is Interderm something I will need to use for a long time?

Regulatory documents mandate that the treatment course for Interderm must be short-term. The maximum duration of use is often limited to a period such as 14 to 25 days, according to official administration guidelines.


Q: If I miss a scheduled application of Interderm, what do official documents suggest?

If an application is missed, official consumer information suggests applying it as soon as it is remembered. However, if it is almost time for the next scheduled application, the application should be skipped, and the regular schedule should be continued. It is advised not to use a double application to make up for a missed one.


Q: What are the known components of Interderm besides the active ingredient?

The product contains inactive components that form the base, in addition to the three active ingredients. For example, the cream base typically includes purified water, mineral oil, emulsifying wax, and certain preservatives like sorbic acid and potassium sorbate, which are included in the final topical formulation.


Q: Is there any evidence about using Interderm during pregnancy or while breastfeeding?

For pregnant patients, use is conditional, meaning its use is permitted only if the potential benefit is determined to justify the potential risks. Official information notes that it is not known whether components of this preparation are excreted in human milk, so caution is generally advised for nursing mothers.


Q: How to Store and Dispose of Interderm?

Interderm must be stored at a Controlled Room Temperature (between 20 C to 25 C) and protected from freezing, heat, moisture, and light. For disposal, unused or expired product should be returned via a medicine take-back program if available. If this option is unavailable, guidance suggests mixing the product with an undesirable substance before disposal in the household trash, in line with local regulations.


Q: Can Interderm be used for conditions not listed in the official documents?

Official patient information advises that this medicine should not be used for any disorder other than the one for which it was prescribed. The medicine is approved specifically for the conditions outlined in the product labeling.


Q: Can Interderm be used by children, and if so, what are the age limits described?

Safety and effectiveness have not been established in patients younger than 2 months of age. Official guidance advises that administration in children should use the least amount compatible with an effective treatment plan, due to this population's increased susceptibility to potential systemic effects.


Q: Can Interderm interact with common vitamins or herbal supplements?

While official labeling primarily cautions against concurrent use with specific prescription medications, precautions advise that patients should inform their healthcare professional about all prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products they are taking or plan to take.


Q: How does Interderm affect the immune system?

The Triamcinolone Acetonide component is classified as a synthetic glucocorticoid. The absorbed corticosteroid is handled similarly to systemically administered corticosteroids and can produce reversible suppression of the HPA axis (a system regulating hormonal response).


Q: What happens if I use more Interderm than described in the directions?

Increased systemic exposure raises the potential for systemic effects, such as the suppression of the HPA axis. This increased absorption can occur if the medication is used on large skin areas, for prolonged periods, or when the application site is covered with occlusive dressings.


Q: Can Interderm be used for very sensitive skin areas?

Official instructions state the product is for external use only. Some patient resources advise against application to highly sensitive areas like the face, underarms, or groin unless a healthcare professional specifically instructs otherwise.


Q: Does using Interderm require any special lab tests or monitoring?

Monitoring is generally based on the extent and duration of use. If there are clinical signs of potential HPA axis suppression (a potential effect from the corticosteroid), monitoring may be required. This can involve periodic evaluations of specific tests like the urinary free cortisol test and the ACTH stimulation test.


Q: What is the chance of a serious side effect happening with Interderm?

Official information lists both common and serious adverse reactions. Clinical studies found that common adverse events were most frequently reported, generally confined to the application site. While serious adverse reactions are listed in official warnings, their specific frequency rates are not consistently provided for all serious adverse reactions.


Q: Is Interderm safe to use near the eyes or mouth?

Official patient instructions state that Interderm is for external dermatologic use only and is not approved for ophthalmic (eye) use. Contact with the eyes and mouth must be avoided during application.


Q: What is the difference between the cream and ointment versions of Interderm?

The cream and ointment forms contain the same three active ingredients, but they are mixed into different inactive components, or bases. The ointment base often uses mineral oil and white petrolatum, while the cream base includes water and emulsifying agents, resulting in different textures and base characteristics.


Q: Can I apply makeup or other products over the area where I use Interderm?

The treated skin area should not be covered or wrapped in a way that creates an occlusive dressing. The primary restriction relates to anything that substantially covers or seals the area, as this increases drug absorption.


Q: Can Interderm cause rebound effects if stopped suddenly?

Prolonged and inappropriate use of topical corticosteroids may sometimes lead to a reaction upon cessation, which is sometimes referred to as Topical Corticosteroid Withdrawal. This reaction may involve symptoms such as redness, burning pain, and peeling skin in the treated area.


Q: How long does it take for the active ingredient in Interderm to leave the body?

The rate at which the medication leaves the body is determined by factors including the condition of the skin barrier and the application method. Once absorbed, the corticosteroid component is primarily metabolized in the liver and eliminated by the kidneys and bile, with the total half-life of one active component being approximately 36 hours.


Q: If Interderm is not working after a few weeks, what should be done?

If a patient experiences a lack of prompt response to the anti-infective therapy, official guidance advises that the corticosteroid component should be discontinued. A re-evaluation is often needed if there is no improvement, given the mandated short-term nature of the therapy.


Q: Why is Interderm not recommended for everyone with the treated condition?

The medicine is strictly contraindicated (not allowed) for anyone with a known history of allergy or hypersensitivity to any of its components. Caution is also required for patients with comorbidities like active infections, as these conditions require caution during treatment.


Q: Does Interderm affect other prescription medications I might be taking?

Official drug interaction warnings caution against the co-administration with other nephrotoxic (kidney-damaging) and ototoxic (ear-damaging) agents. This is due to the potential for additive toxicity resulting from the systemic absorption of one of the active components.


Q: Are there any common foods or drinks that should be avoided while using Interderm?

While the main regulatory warnings focus on drug-to-drug interactions, information regarding the corticosteroid component sometimes notes that consumption of grapefruit or grapefruit juice may be limited or avoided, as it may affect the way the medication is metabolized in the body.


Q: Is it normal to feel a mild tingling sensation when first starting Interderm?

Clinical trials reported that common adverse events confined to the application site include temporary burning, irritation, and dry skin. Although tingling may not be explicitly listed, it is similar to the reported feelings of temporary irritation experienced when first starting the medication.


Q: Why do some people experience initial irritation when starting Interderm?

Official prescribing information lists local irritation as a possible adverse event. This temporary reaction may be related to the local effects of the active corticosteroid component.

How should Interderm be stored and disposed of?

How to Store and Dispose of Interderm

Interderm (Nystatin and Triamcinolone Acetonide combination) must be stored according to official regulatory conditions to maintain its stability and effectiveness.


Storage Conditions

This medication must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). It is mandatory to protect the product from freezing and store it away from excess heat, moisture, and direct light. The container must be kept tightly closed and remain in its original packaging. Like all medications, Interderm must be stored out of the reach and sight of children.


Disposal Instructions

Unused or expired Interderm must be discarded according to established protocols. Disposal must comply with all local and national regulations. The recommended method is to use a medicine take-back program. If this is unavailable, the product should be mixed with an undesirable substance (such as dirt) and sealed in a container before being placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Interderm found in:

A-Z Index: